Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5

Abstract Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Osteoprotegerin (OPG), known to regulate bone mass by inhibiting osteoclast differentiation and activation, might also play a role in vascular calcification. Increased circulating OPG l...

Full description

Bibliographic Details
Main Authors: Gustavo Lenci Marques, Shirley Hayashi, Anna Bjällmark, Matilda Larsson, Miguel Riella, Marcia Olandoski, Bengt Lindholm, Marcelo Mazza Nascimento
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-82072-z

Internet

https://doi.org/10.1038/s41598-021-82072-z

Similar Items